======= ZNF281 =======
== Gene Information ==
* **Official Symbol**: ZNF281
* **Official Name**: zinc finger protein 281
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=23528|23528]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9Y2X9|Q9Y2X9]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=ZNF281&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ZNF281|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/618703|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Transcription repressor that plays a role in regulation of embryonic stem cells (ESCs) differentiation. Required for ESCs differentiation and acts by mediating autorepression of NANOG in ESCs: binds to the NANOG promoter and promotes association of NANOG protein to its own promoter and recruits the NuRD complex, which deacetylates histones. Not required for establishement and maintenance of ESCs (By similarity). Represses the transcription of a number of genes including GAST, ODC1 and VIM. Binds to the G- rich box in the enhancer region of these genes. {ECO:0000250, ECO:0000269|PubMed:10448078, ECO:0000269|PubMed:12771217}.
No Pfam Domain information is available for this gene.
|embryonic body morphogenesis|
|body morphogenesis|
|RNA polymerase II distal enhancer sequence-specific DNA binding|
|stem cell differentiation|
|transcription regulatory region DNA binding|
|transcription corepressor activity|
|DNA-binding transcription repressor activity, RNA polymerase II-specific|
|sequence-specific DNA binding|
|RNA polymerase II proximal promoter sequence-specific DNA binding|
|embryonic morphogenesis|
|DNA-binding transcription factor activity|
|negative regulation of transcription by RNA polymerase II|
|embryo development|
|negative regulation of transcription, DNA-templated|
|negative regulation of nucleic acid-templated transcription|
|negative regulation of RNA biosynthetic process|
|negative regulation of RNA metabolic process|
|negative regulation of cellular macromolecule biosynthetic process|
|negative regulation of nucleobase-containing compound metabolic process|
|DNA binding|
|negative regulation of macromolecule biosynthetic process|
|negative regulation of cellular biosynthetic process|
|positive regulation of transcription, DNA-templated|
|negative regulation of biosynthetic process|
|DNA-binding transcription factor activity, RNA polymerase II-specific|
|positive regulation of nucleic acid-templated transcription|
|positive regulation of RNA biosynthetic process|
|negative regulation of gene expression|
|positive regulation of RNA metabolic process|
|positive regulation of nucleobase-containing compound metabolic process|
|positive regulation of macromolecule biosynthetic process|
|positive regulation of cellular biosynthetic process|
|positive regulation of gene expression|
|positive regulation of biosynthetic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp93|DABN racemic mixture R03 exp93]]|-1.96|
|[[:results:exp515|PU-H71 1μM R08 exp515]]|-1.88|
|[[:results:exp500|LY2090314 0.003μM R08 exp500 no dilution day6]]|1.73|
|[[:results:exp393|Resminostat 0.5μM R07 exp393]]|1.83|
|[[:results:exp499|LY2090314 0.003μM R08 exp499]]|2.58|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 2/726
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|1/28|
|bone|0/25|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/15|
|kidney|0/21|
|liver|1/20|
|lung|0/75|
|lymphocyte|0/14|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/7|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 4507
* **Expression level (log2 read counts)**: 5.98
{{:chemogenomics:nalm6 dist.png?nolink |}}